These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 355684)

  • 1. Production of trypsin-activable toxic components by Clostridium botulinum types C and D [proceedings].
    Nakane A; Oguma K; Shiozaki M; Iida H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):166-9. PubMed ID: 355684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A
    Nihon Saikingaku Zasshi; 1977 Nov; 32(6):805-11. PubMed ID: 342740
    [No Abstract]   [Full Text] [Related]  

  • 3. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Inoue K; Iida H
    Jpn J Med Sci Biol; 1971 Feb; 24(1):53-6. PubMed ID: 4931809
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteriophages and Toxigencity in Clostridium Botulinum types C and D.
    Oguma K; Iida H; Inove K
    Schweiz Med Wochenschr; 1975 Dec; 105(51):548-52. PubMed ID: 766180
    [No Abstract]   [Full Text] [Related]  

  • 5. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Iida H; Oguma K; Inoue K
    Jpn J Med Sci Biol; 1974 Apr; 27(2):101-3. PubMed ID: 4601039
    [No Abstract]   [Full Text] [Related]  

  • 6. Adsorption of Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K; Iida H; Sugiyama H
    Jpn J Med Sci Biol; 1979 Apr; 32(2):125-6. PubMed ID: 396393
    [No Abstract]   [Full Text] [Related]  

  • 7. C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin.
    Nakamura S; Serikawa T; Yamakawa K; Nishida S; Kozaki S; Sakaguchi G
    Jpn J Med Sci Biol; 1979 Apr; 32(2):128-9. PubMed ID: 396395
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity.
    Ohishi I; Sakaguchi G
    Infect Immun; 1982 Jan; 35(1):1-4. PubMed ID: 7033132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxigenicity and bacteriophages of Clostridium botulinum].
    Oguma K
    Nihon Saikingaku Zasshi; 1974 Jul; 29(4):665-9. PubMed ID: 4613878
    [No Abstract]   [Full Text] [Related]  

  • 10. The taxonomic position of Clostridium botulinum type c.
    Jansen BC; Knoetze PC
    Onderstepoort J Vet Res; 1977 Jun; 44(2):53-4. PubMed ID: 351507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation].
    Lysenko AI; Cherniavskiĭ VI; Kulakova GS; Iskritskiĭ GV
    Mikrobiol Zh; 1973; 35(3):308-12. PubMed ID: 4598684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)].
    Iida H
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():31-44. PubMed ID: 800280
    [No Abstract]   [Full Text] [Related]  

  • 13. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stability of toxigenicity in Clostridium botulinum types C and D.
    Oguma K
    J Gen Microbiol; 1976 Jan; 92(1):67-75. PubMed ID: 1107486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.
    Kouguchi H; Suzuki T; Hasegawa K; Mutoh S; Watanabe T; Niwa K; Yoneyama T; Katoh Y; Ohyama T
    J Microbiol Methods; 2006 Dec; 67(3):416-23. PubMed ID: 16725219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and toxin production of Clostridium botulinum types E, nonproteolytic B, and F in nonirradiated and irradiated fisheries products in the temperature range of 36 degrees to 72 degrees F. TID-24881.
    Eklund MW; Poysky FT; Wieler DI
    TID Rep; 1966 Jan; ():1-86. PubMed ID: 4905224
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteases of Clostridium botulinum. VI. The role of trypsin, Clostridium botulinum proteases and protease inhibitors in the formation and activation of toxin in growing cultures of Clostridium botulinum.
    Tjaberg TB
    Acta Vet Scand; 1974; 15(4):487-506. PubMed ID: 4616624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and stability of the nontoxic component of the botulinum toxin complex.
    Miyata K; Yoneyama T; Suzuki T; Kouguchi H; Inui K; Niwa K; Watanabe T; Ohyama T
    Biochem Biophys Res Commun; 2009 Jun; 384(1):126-30. PubMed ID: 19394306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extrachromosomal genetic elements of Clostridium botulinum. I. Plasmids of toxigenic and atoxigenic strains of Clostridium botulinum type A].
    Evstigneev VI; Smirnov EV; Rudoĭ BA; Surkov SV; Supotnitskiĭ MV; Telitsyn AM
    Mol Gen Mikrobiol Virusol; 1993; (2):16-21. PubMed ID: 8515745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of water activity and pH on growth and toxin production by Clostridium botulinum type G.
    Briozzo J; de Lagarde EA; Chirife J; Parada JL
    Appl Environ Microbiol; 1986 Apr; 51(4):844-8. PubMed ID: 3518631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.